Approval · Notice of Compliance 4631 · 1996
ZANTEFF: Notice of Compliance 4631
Issued March 7, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4631
- Date
- March 7, 1996
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Histamine H2-receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZANTEFF | 02213494 | — |
| ZANTEFF | 02213508 | — |
| ZANTEFF | 02213516 | — |
| ZANTEFF | 02213524 | — |
Medicinal ingredients
- RANITIDINE HCL 150 MG per TAB
- RANITIDINE HCL 300 MG per TAB
- RANITIDINE HCL 150 MG per PCK
- RANITIDINE HCL 300 MG per PCK